cytochrome-c-t and Coronary-Disease

cytochrome-c-t has been researched along with Coronary-Disease* in 3 studies

Trials

2 trial(s) available for cytochrome-c-t and Coronary-Disease

Article	Year
Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease. Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:1 Composite preparation refracterin administered in a dose of 300 mg/day for 3 days in addition to routine therapy significantly improved the results of treatment of severe cardiac insufficiency of ischemic genesis compared to placebo. Improvement of clinical status of patients is determined by positive dynamics of systolic and diastolic functions of the left ventricle. Topics: Acetyldigoxins; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Male; Middle Aged; NAD; Oxyfedrine; Systole; Treatment Outcome; Ventricular Function, Left	2004
Energostim in therapy of chronic ischemia of the lower limbs. Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:2 Positive changes were more pronounced in patients with chronic ischemia of the lower limbs treated with energostim alone and in combination with trental in comparison with patients receiving trental monotherapy. The best effect was attained in patients treated with energostim in combination with trental. Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Ischemia; Laser-Doppler Flowmetry; Leg; Male; Microcirculation; Middle Aged; NAD; Pentoxifylline	2004

Article

Year

Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease.

Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:1

Composite preparation refracterin administered in a dose of 300 mg/day for 3 days in addition to routine therapy significantly improved the results of treatment of severe cardiac insufficiency of ischemic genesis compared to placebo. Improvement of clinical status of patients is determined by positive dynamics of systolic and diastolic functions of the left ventricle.

Topics: Acetyldigoxins; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Male; Middle Aged; NAD; Oxyfedrine; Systole; Treatment Outcome; Ventricular Function, Left

2004

Energostim in therapy of chronic ischemia of the lower limbs.

Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:2

Positive changes were more pronounced in patients with chronic ischemia of the lower limbs treated with energostim alone and in combination with trental in comparison with patients receiving trental monotherapy. The best effect was attained in patients treated with energostim in combination with trental.

Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Coronary Disease; Cytochromes c; Drug Combinations; Echocardiography; Female; Humans; Inosine; Ischemia; Laser-Doppler Flowmetry; Leg; Male; Microcirculation; Middle Aged; NAD; Pentoxifylline

2004

Other Studies

1 other study(ies) available for cytochrome-c-t and Coronary-Disease

Article	Year
[Clinical and experimental research on effects of cytochrome C on phenomena of myocardial anoxia]. La Riforma medica, 1953, Jul-11, Volume: 67, Issue:28 Topics: Coronary Disease; Cytochromes; Cytochromes c; Electrocardiography; Hypoxia; Myocardium	1953